• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

prudence.francis@unimelb.edu.au

Credentials


Position
Clinical (Professor)
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-7207-9286

Prof Prudence A. Francis

Clinical (Professor)
The Sir Peter MacCallum Department of Oncology

254 Scholarly works
4 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Identifying premenopausal patients with early-stage hormone receptor–positive breast cancer at minimal risk of distant recurrence by breast cancer index
    DOI: 10.1016/j.breast.2026.104714
  • 2026

    Journal article

    A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast Cancer
    DOI: 10.1002/pon.70418
  • 2026

    Journal article

    Abstract PS3-07-27: Identifying Premenopausal Patients with Early-Stage Hormone Receptor-Positive Node-Negative Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index
    DOI: 10.1158/1557-3265.sabcs25-ps3-07-27
  • 2021

    Journal article

    Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
    DOI: 10.1093/jnci/djab111
  • 2021

    Research Grant

    Understanding Response to Neoadjuvant Therapy in Hormone Receptor Positive Breast Cancer: A Correlative Analysis of the ELIMINATE Trial
  • 2018

    Research Grant

    Capture: Circulating Tumour Dna Assessment of Pik3ca to Guide Treatment Response
  • 2016

    Research Grant

    Randomised Phase Iii Trial of Adjuvant Radiotherapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Low-Risk Luminal a Early Breast Cancer
Prudence A. Francis

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Abstract PS5-04-07: Real world experience with trastuzumab deruxtecan for metastatic breast cancer at a major Australian cancer centre
    DOI: 10.1158/1557-3265.sabcs25-ps5-04-07
  • 2026

    Journal article

    Abstract PD7-10: Neo-n (neon): three-year event-free survival and ultrasensitive ctdna dynamics in early triple-negative breast cancer (tnbc) treated with neoadjuvant carboplatin/paclitaxel and nivolumab
    DOI: 10.1158/1557-3265.sabcs25-pd7-10
  • 2026

    Journal article

    Evaluating the Sleep Cancer Rest (SleepCaRe) Trial for Improving Health-Related Quality of Life (HRQoL) in Women Undergoing Chemotherapy for Breast Cancer - A Randomised Controlled Trial
    DOI: 10.1016/j.sleep.2025.108351
  • 2026

    Journal article

    Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
    DOI: 10.1056/NEJMoa2511218
  • 2026

    Journal article

    Pharmacological treatment of early-stage breast cancer: Key discussions at the 19th International St. Gallen Consensus Conference
    DOI: 10.1007/s00761-025-01879-x
  • 2025

    Journal article

    Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer
    DOI: 10.1016/j.annonc.2025.09.007
  • 2025

    Journal article

    Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors
    DOI: 10.1016/j.breast.2025.104586

RECENT PROJECTS

  • 2015

    Research Grant

    The Landscape of Cancer Genes and Associations With Prognosis in Breast Cancer Diagnosed in Premenopausal Women

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224